Elodie Belnoue

Elodie Belnoue is a seasoned professional in the field of immunology, currently serving as Senior Director of Translational Research and In vivo Research, as well as Head of Research at Amal Therapeutics since 2014, where expertise is applied in the development of cancer vaccines. Prior experience includes a role as Project Manager focused on cancer vaccine development. Between 2003 and 2014, Elodie Belnoue held the position of Maître assistante at Université de Genève, conducting significant research on neonatal T cell immunity, innate immune responses, and preclinical studies of vaccine adjuvants. Earlier roles included Post-Doctoral research at both Université de Genève and Institut Cochin, where work concentrated on neonatal immunity and immunotherapies for hepatic tumors. Elodie Belnoue earned a PhD in Immunology from Université Paris Cité in 2002.